Clinical Trial

Multiparametric SCores for Prediction of Myocardial fIbrosis in Patients With MITral vAlve pRolapse

Study acronym: SCIMITAR
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 3, 2026 (before its estimated June 19, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a multicenter, observational prospective and retrospective study which aims are: 1) to compute a scoring model potentially predictive for the diagnosis of fibrosis by CMR in patients with MVP; 2) to identify specific features that may predispose to ≥ mild VAs or SCD in patients with MVP.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-03-25; most recent amendment 2026-01-30.
Trial Details
NCT Number NCT06341166
Lead Sponsor Centro Cardiologico Monzino
Collaborators: Humanitas Hospital, Italy, IRCCS Ospedale San Raffaele, Azienda Ulss 2 Marca Trevigiana
Conditions Mitral Valve Prolapse
Enrollment 300 participants
Start Date 2023-06-19
Primary Completion 2026-06-19 (estimated)
Study Completion 2026-06-19 (estimated)
Updated on ClinicalTrials.gov 2026-02-03